Comparison of two analgesic combinations for reno-ureteral colic treatment

Not Applicable

• Conditions: Reno-ureteral colic management; Urological and Genital Diseases

• Registration Number: ISRCTN13320231
• Lead Sponsor: Mexican Social Security Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-04-04
• Last Update Posted: 12 September 2022
• Study Completion: 2022-09-20

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

1. Aged 20 to 60 years
2. Clinical signs and symptoms of reno-ureteral colic

Exclusion Criteria

1. Hypersensitivity to any of the tested drug formulations
2. Patients with severe reno- ureteral colic (with fever and chronic pain)
3. Grade III and IV renal insufficiency
4. Patients will be excluded if they have any pre-existing treatment that might interact with the tested drug
5. Patients will be excluded if they possess pre-existing digestive tube bleeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain is measured using a visual analogue scale (VAS) at baseline, 10, 20, and 45 min

Secondary Outcome Measures

Name	Time	Method
The brief pain inventory (short form in Spanish) will be applied to assess the severity of pain and its impact on functioning at baseline